Abstract
Development of fluorescence standards may help improve the comparison between near-infrared fluorescence imaging devices, especially if they become commercially available. As translation of optical imaging for oncologic resections puts these techniques into the hands of more surgeons and operating personnel, improving the ability to compare results between devices and the simplicity of the device will be critical to improve adoption of this technology.
References
Zhu B, Wu G, Robinson H et al (2013) Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. Molec Imaging Biol. doi:10.1007/s11307-013-0637-8
Sevick-Muraca E, Zhu B (2013) The need for performance standards in clinical translation and adoption of fluorescence molecular imaging. Med Phys 40(4):040402. doi:10.1118/1.4789499
Keereweer S, Kerrebijn JD, van Driel PB et al (2011) Optical image-guided surgery—where do we stand? Mol Imaging Biol 13:199–207
Day KE, Beck LN, Deep NL et al (2013) Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope. doi:10.1002/lary.24102
Heath CH, Deep NL, Beck LN et al Use of Panitumumab-IRDye800 to Image Cutaneous Head and Neck Cancer in Mice. Otolaryngol Head Neck Surg. doi:10.1177/0194599813482290
Day KE, Beck LN, Heath CH et al (2013) Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther 14:271–277
Cohen R, Stammes MA, de Roos IH et al (2011) Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. Eir J Nucl Med Molec Imaging Res 1:31–44
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosenthal, E.L., Zinn, K.R. Putting Numbers to Fluorescent Guided Surgery. Mol Imaging Biol 15, 647–648 (2013). https://doi.org/10.1007/s11307-013-0662-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-013-0662-7